Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy; School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.
Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.
J Cardiothorac Vasc Anesth. 2022 May;36(5):1354-1363. doi: 10.1053/j.jvca.2021.11.032. Epub 2021 Nov 27.
Patients with COVID-19 frequently develop acute respiratory distress syndrome (ARDS) requiring intensive care unit (ICU) admission. Data on long-term survival of these patients are lacking. The authors investigated 1-year survival, quality of life, and functional recovery of patients with COVID-19 ARDS requiring invasive mechanical ventilation.
Prospective observational study.
Tertiary-care university hospital.
All patients with COVID-19 ARDS receiving invasive mechanical ventilation and discharged alive from hospital.
Patients were contacted by phone after 1 year. Functional, cognitive, and psychological outcomes were explored through a questionnaire and assessed using validated scales. Patients were offered the possibility to undergo a follow-up chest computed tomography (CT) scan.
The study included all adult (age ≥18 years) patients with COVID-19-related ARDS admitted to an ICU of the authors' institution between February 25, 2020, and April 27, 2020, who received at least 1 day of invasive mechanical ventilation (IMV). Of 116 patients who received IMV, 61 (52.6%) survived to hospital discharge. These survivors were assessed 1 year after discharge and 56 completed a battery of tests of cognition, activities of daily living, and interaction with family members. They had overall good functional recovery, with >80% reporting good recovery and no difficulties in usual activities. A total of 52 (93%) of patients had no dyspnea at rest. Severe anxiety/depression was reported by 5 (8.9%) patients. Comparing 2-month and 1-year data, the authors observed the most significant improvements in the areas of working status and exertional dyspnea. One-year chest CT scans were available for 36 patients; fibrotic-like changes were present in 4 patients.
All patients who survived the acute phase of COVID-19 and were discharged from the hospital were alive at the 1-year follow up, and the vast majority of them had good overall recovery and quality of life.
患有 COVID-19 的患者常发生需要入住重症监护病房(ICU)的急性呼吸窘迫综合征(ARDS)。这些患者的长期生存数据尚缺乏。作者调查了需要有创机械通气的 COVID-19 ARDS 患者的 1 年生存率、生活质量和功能恢复情况。
前瞻性观察性研究。
三级保健大学医院。
所有接受有创机械通气和从医院出院存活的 COVID-19 ARDS 患者。
患者在 1 年后通过电话联系。通过问卷探讨功能、认知和心理结局,并使用经过验证的量表进行评估。患者有机会接受随访胸部计算机断层扫描(CT)检查。
该研究纳入了 2020 年 2 月 25 日至 4 月 27 日期间入住作者所在机构 ICU 的所有患有 COVID-19 相关 ARDS 的成年(年龄≥18 岁)患者,他们接受了至少 1 天的有创机械通气(IMV)。116 名接受 IMV 的患者中,61 名(52.6%)存活至出院。这些幸存者在出院后 1 年进行评估,其中 56 名完成了认知、日常生活活动和与家庭成员互动的一系列测试。他们总体上功能恢复良好,超过 80%的患者报告恢复良好,没有日常活动的困难。共有 52 名(93%)患者在休息时无呼吸困难。5 名(8.9%)患者报告有严重的焦虑/抑郁。作者观察到,与 2 个月相比,工作状态和运动性呼吸困难领域的改善最显著。1 年的胸部 CT 扫描可用于 36 名患者;4 名患者存在纤维化样改变。
所有从 COVID-19 急性期出院并存活至 1 年随访的患者仍存活,绝大多数患者总体恢复良好,生活质量较高。